pRb phosphorylation is regulated differentially by cyclin-dependent kinase (Cdk) 2 and Cdk4 in retinoic acid-induced neuronal differentiation of P19 cells

被引:30
作者
Watanabe, Y
Watanabe, T
Kitagawa, M
Taya, Y
Nakayama, K
Motoyama, N
机构
[1] Kyushu Univ, Med Inst Bioregulat, Dept Mol Immunol, Higashi Ku, Fukuoka 8128582, Japan
[2] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan
[3] Natl Canc Ctr, Inst Res, Div Biol, Chuo Ku, Tokyo 1040045, Japan
基金
日本学术振兴会;
关键词
retinoblastoma protein; embryonal carcinoma cell; neuronal differentiation; site-specific anti-phospho-pRb antibody; cyclin-dependent kinase;
D O I
10.1016/S0006-8993(99)01844-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The retinoblastoma protein (pRb) is a key regulator of cell growth, differentiation and survival. pRb(-/-) mice show abnormal neuronal cell death in the developing brain. The function of pRb is regulated by its phosphorylation state. In this study, the phosphorylation of pRb during retinoic acid (RA)-induced neuronal differentiation of P19 cells was examined using site-specific antibodies against pRb phosphorylated at Ser601, Ser605 and Ser773. Although pRb was hyperphosphorylated in undifferentiated P19 cells, Ser601 and Ser773 were not phosphorylated. Upon exposure to RA, however, these two sites became strongly phosphorylated, Cdk4 kinase activity was almost undetectable in undifferentiated P19 cells, but was strongly activated on exposure to RA. In contrast, Cdk2 kinase activity and the phosphorylation of Ser605 were observed in undifferentiated cells as well as in RA-treated cells. These observations suggest that Cdk2 and Cdk4 may phosphorylate different sites of pRb in vivo and that the two sites of pRb examined here are newly phosphorylated during RA-induced neuronal differentiation in P19 cells. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:342 / 350
页数:9
相关论文
共 39 条
  • [1] BOTH P16 AND P21 FAMILIES OF CYCLIN-DEPENDENT KINASE (CDK) INHIBITORS BLOCK THE PHOSPHORYLATION OF CYCLIN-DEPENDENT KINASES BY THE CDK-ACTIVATING KINASE
    APRELIKOVA, O
    XIONG, Y
    LIU, ET
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (31) : 18195 - 18197
  • [2] FROM EMBRYONAL CARCINOMA-CELLS TO NEURONS - THE P19 PATHWAY
    BAIN, G
    RAY, WJ
    YAO, M
    GOTTLIEB, DI
    [J]. BIOESSAYS, 1994, 16 (05) : 343 - 348
  • [3] STRUCTURE AND EXPRESSION OF THE MURINE RETINOBLASTOMA GENE AND CHARACTERIZATION OF ITS ENCODED PROTEIN
    BERNARDS, R
    SCHACKLEFORD, GM
    GERBER, MR
    HOROWITZ, JM
    FRIEND, SH
    SCHARTL, M
    BOGENMANN, E
    RAPAPORT, JM
    MCGEE, T
    DRYJA, TP
    WEINBERG, RA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (17) : 6474 - 6478
  • [4] Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs
    Chen, PL
    Riley, DJ
    Chen, YM
    Lee, WH
    [J]. GENES & DEVELOPMENT, 1996, 10 (21) : 2794 - 2804
  • [5] REQUIREMENT FOR A FUNCTIONAL RB-1 GENE IN MURINE DEVELOPMENT
    CLARKE, AR
    MAANDAG, ER
    VANROON, M
    VANDERLUGT, NMT
    VANDERVALK, M
    HOOPER, ML
    BERNS, A
    RIELE, HT
    [J]. NATURE, 1992, 359 (6393) : 328 - 330
  • [6] Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation
    ConnellCrowley, L
    Harper, JW
    Goodrich, DW
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1997, 8 (02) : 287 - 301
  • [7] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION
    ELDEIRY, WS
    TOKINO, T
    VELCULESCU, VE
    LEVY, DB
    PARSONS, R
    TRENT, JM
    LIN, D
    MERCER, WE
    KINZLER, KW
    VOGELSTEIN, B
    [J]. CELL, 1993, 75 (04) : 817 - 825
  • [8] INTERACTION OF MYOGENIC FACTORS AND THE RETINOBLASTOMA PROTEIN MEDIATES MUSCLE-CELL COMMITMENT AND DIFFERENTIATION
    GU, W
    SCHNEIDER, JW
    CONDORELLI, G
    KAUSHAL, S
    MAHDAVI, V
    NADALGINARD, B
    [J]. CELL, 1993, 72 (03) : 309 - 324
  • [9] CELL-CYCLE REGULATION OF CDK2 ACTIVITY BY PHOSPHORYLATION OF THR160 AND TYR15
    GU, Y
    ROSENBLATT, J
    MORGAN, DO
    [J]. EMBO JOURNAL, 1992, 11 (11) : 3995 - 4005
  • [10] HAMEL PA, 1992, ONCOGENE, V7, P693